{"disease":{"id":"glucocorticoid","name":"glucocorticoid"},"drugs":{"marketed":[{"drug_id":"risedronate","indication_name":"Glucocorticoid Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Risedronate","company_name":"Toronto Rehabilitation Institute","drug_phase":"marketed","molecular_target":"Butyrophilin subfamily 3 member A1, Farnesyl pyrophosphate synthase, Farnesyl diphosphate synthase","drug_class":"","quality_score":38,"revenue":null,"mechanism":null},{"drug_id":"risedronate","indication_name":"Prevention of Glucocorticoid-Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Risedronate","company_name":"Toronto Rehabilitation Institute","drug_phase":"marketed","molecular_target":"Butyrophilin subfamily 3 member A1, Farnesyl pyrophosphate synthase, Farnesyl diphosphate synthase","drug_class":"","quality_score":38,"revenue":null,"mechanism":null},{"drug_id":"colecalciferol","indication_name":"Glucocorticoid Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Infuvite Adult","generic_name":"Colecalciferol","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Vitamin D3 receptor","drug_class":"Vitamin D","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cholecalciferol","indication_name":"Glucocorticoid Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vitamin D3","generic_name":"cholecalciferol","company_name":"","drug_phase":"marketed","molecular_target":"Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Sterol 26-hydroxylase, mitochondrial","drug_class":"Vitamin C [EPC]","quality_score":27,"revenue":null,"mechanism":null},{"drug_id":"ergocalciferol","indication_name":"Glucocorticoid Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Drisdol","generic_name":"ERGOCALCIFEROL","company_name":"Esjay Pharma","drug_phase":"marketed","molecular_target":"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial","drug_class":"Provitamin D2 Compound [EPC]","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"calciferol","indication_name":"Glucocorticoid Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Calciferol","company_name":"Department of Medical Services Ministry of Public Health of Thailand","drug_phase":"phase_1","molecular_target":"Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D3 receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"alendronate","indication_name":"Glucocorticoid Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"alendronate","company_name":"Massachusetts General Hospital","drug_phase":"marketed","molecular_target":"Farnesyl pyrophosphate synthase, Farnesyl pyrophosphate synthase, Farnesyl pyrophosphate synthase, EC 2.5.1.1, EC 2.5.1.10","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"alendronate","indication_name":"Prevention of Glucocorticoid-Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"alendronate","company_name":"Massachusetts General Hospital","drug_phase":"marketed","molecular_target":"Farnesyl pyrophosphate synthase, Farnesyl pyrophosphate synthase, Farnesyl pyrophosphate synthase, EC 2.5.1.1, EC 2.5.1.10","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"alendronic-acid","indication_name":"Glucocorticoid Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fosamax","generic_name":"ALENDRONIC ACID","company_name":"Merck And Co Inc","drug_phase":"marketed","molecular_target":"Farnesyl pyrophosphate synthase","drug_class":"Vitamin D [EPC]","quality_score":63,"revenue":null,"mechanism":"Fosamax works by inhibiting bone resorption, allowing bone density to increase."},{"drug_id":"alendronic-acid","indication_name":"Prevention of Glucocorticoid-Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fosamax","generic_name":"ALENDRONIC ACID","company_name":"Merck And Co Inc","drug_phase":"marketed","molecular_target":"Farnesyl pyrophosphate synthase","drug_class":"Vitamin D [EPC]","quality_score":63,"revenue":null,"mechanism":"Fosamax works by inhibiting bone resorption, allowing bone density to increase."},{"drug_id":"zoledronic-acid","indication_name":"Glucocorticoid Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zometa","generic_name":"ZOLEDRONIC ACID","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Farnesyl pyrophosphate synthase","drug_class":"zoledronic acid","quality_score":80,"revenue":null,"mechanism":"Zometa works by inhibiting the enzyme farnesyl pyrophosphate synthase, which is involved in the mevalonate pathway and ultimately leads to the inhibition of osteoclast activity."},{"drug_id":"zoledronic-acid","indication_name":"Prevention of Glucocorticoid-Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zometa","generic_name":"ZOLEDRONIC ACID","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Farnesyl pyrophosphate synthase","drug_class":"zoledronic acid","quality_score":80,"revenue":null,"mechanism":"Zometa works by inhibiting the enzyme farnesyl pyrophosphate synthase, which is involved in the mevalonate pathway and ultimately leads to the inhibition of osteoclast activity."},{"drug_id":"zometa","indication_name":"Glucocorticoid Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zometa","company_name":"University of Arkansas","drug_phase":"marketed","molecular_target":"Butyrophilin subfamily 3 member A1, 72 kDa type IV collagenase, Geranylgeranyl pyrophosphate synthase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"zometa","indication_name":"Prevention of Glucocorticoid-Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zometa","company_name":"University of Arkansas","drug_phase":"marketed","molecular_target":"Butyrophilin subfamily 3 member A1, 72 kDa type IV collagenase, Geranylgeranyl pyrophosphate synthase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"zoledronate","indication_name":"Glucocorticoid Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zoledronate","company_name":"Children's Hospital Medical Center, Cincinnati","drug_phase":"marketed","molecular_target":"Butyrophilin subfamily 3 member A1, 72 kDa type IV collagenase, Geranylgeranyl pyrophosphate synthase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"zoledronate","indication_name":"Prevention of Glucocorticoid-Induced Osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zoledronate","company_name":"Children's Hospital Medical Center, Cincinnati","drug_phase":"marketed","molecular_target":"Butyrophilin subfamily 3 member A1, 72 kDa type IV collagenase, Geranylgeranyl pyrophosphate synthase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":16,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03575247","title":"The Risk of Adrenal Insufficiency and Cushing Syndrome Associated With Glucocorticoid Therapy in People With Chronic Inflammatory Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":111804,"lead_sponsor_name":"University of Leeds","has_results":false},{"nct_id":"NCT03788863","title":"A Study to Learn More About the Relationship Between the Development of a Gap in the Upper Lip (Cleft Lip) or in the Roof of the Mouth (Cleft Palate) in Newborns and the Use of Glucocorticoids by the Mother During Pregnancy: a Meta-analysis","phase":"","overall_status":"COMPLETED","enrollment_count":99999,"lead_sponsor_name":"LEO Pharma","has_results":false},{"nct_id":"NCT02365077","title":"GWAS Identified Susceptibility Loci for Glucocorticoid-induced FHN in the Chinese Population","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT01575873","title":"Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":795,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05522465","title":"Short-course High-dose Prednisone and Dexamethasone in Children With ITP","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":608,"lead_sponsor_name":"Fujian Medical University Union Hospital","has_results":false},{"nct_id":"NCT06756750","title":"Clinical Characteristics and Risk Factors for In-Hospital Mortality in Surgical Patients With Abdominal Sepsis","phase":"","overall_status":"COMPLETED","enrollment_count":476,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT04601142","title":"Association Between the Effect of Glucocorticoid Pulse Therapy on Neuromyelitis Optica (NMO) and Gene Polymorphism","phase":"","overall_status":"UNKNOWN","enrollment_count":350,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT05397938","title":"Efficacy and Safety of JMT103 in the Treatment of Glucocorticoid Induced Osteoporosis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":231,"lead_sponsor_name":"Shanghai JMT-Bio Inc.","has_results":false},{"nct_id":"NCT05329740","title":"Glucocorticoids for Post-operative Patients With Acute Type A Aortic Dissection (The GLAD Trial)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":212,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT06208098","title":"Post-corticosteroid Insufficiency: Search for a Threshold Value for Cortisol at 8 Hours, Prospective Study","phase":"NA","overall_status":"UNKNOWN","enrollment_count":170,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT02810496","title":"Mutations of Glucocorticoid Receptor in Bilateral Adrenal Hyperplasia","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"CHU de Reims","has_results":false},{"nct_id":"NCT05598424","title":"CST1 Predictive Model of Oral Glucocorticoid Therapy Sensitivity for Chronic Rhinosinusitis With Polyps","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT03525028","title":"A Clinical Trial of Metformin to Decrease Glucocorticoids Side Effects in Patients With Autoimmune Uveitis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":138,"lead_sponsor_name":"Tianjin Medical University","has_results":false},{"nct_id":"NCT05525065","title":"Investigating the Morbidity of Glucocorticoid Use in Patients With Autoimmune Bullous Diseases (AIBDs)","phase":"","overall_status":"UNKNOWN","enrollment_count":138,"lead_sponsor_name":"Premier Specialists, Australia","has_results":false},{"nct_id":"NCT03125941","title":"High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":true},{"nct_id":"NCT07282223","title":"Contralateral Adrenal Volume Predicts Duration of Postoperative Steroid Replacement Therapy in Non-ACTH-dependent Hypercortisolism","phase":"","overall_status":"COMPLETED","enrollment_count":121,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT05506033","title":"Optimization of Glucocorticoid Taper Strategies for SLE-ITP","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Fujian Medical University Union Hospital","has_results":false},{"nct_id":"NCT07498998","title":"Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":105,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT06588153","title":"A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT05598411","title":"CST1-Guided Oral Glucocorticoids Management for CRSwNP","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT03057717","title":"The Effect of Antenatal Corticosteroids on the Fetal Thymus - a Possible Role in Fetal Immune Programming","phase":"NA","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Unity Health Toronto","has_results":false},{"nct_id":"NCT04091243","title":"Romosozumab Versus Denosumab for Osteoporosis in Long-term Glucocorticoid Users","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Tuen Mun Hospital","has_results":false},{"nct_id":"NCT03667157","title":"Liver Function After Intravenous Methylprednisolone Administration","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT04094298","title":"Use of Extended Release Triamcinolone in the Treatment of Rotator Cuff Disease","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":65,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT01294319","title":"Evaluation of Cortisol Resistance in Young Sedentary and Endurance-Trained Men","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":true},{"nct_id":"NCT06748105","title":"Dapagliflozin as Prophylaxis for Glucocorticoid-Induced Hyperglycemia","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":38,"lead_sponsor_name":"Lauro Fabián Amador Medina","has_results":false},{"nct_id":"NCT03615742","title":"Diesel Exhaust Induces Glucocorticoid Resistance","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT03023891","title":"Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":true},{"nct_id":"NCT06393972","title":"The Efficacy and Safety of Tofacitinib in Patients With Glucocorticoid Resistant ICIs-related Myocarditis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":25,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT03164928","title":"Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05919992","title":"The Role of Glucocorticoids to Maintain Energy Homeostasis During Starvation (Gluco-Starve)","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Eleonora Seelig","has_results":false},{"nct_id":"NCT06556277","title":"Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake","phase":"NA","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Eleonora Seelig","has_results":false},{"nct_id":"NCT04574232","title":"SporTRIA Study: A Multicentre Trial for Excretion Kinetics of Triamcinolone Acetonide Following Sport Related Intra-articular Injections in Knees; Definitions of the Washout Periods","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT05394909","title":"Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA Patients","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Azienda USL Reggio Emilia - IRCCS","has_results":false},{"nct_id":"NCT06724692","title":"Acute Effects of Ultra-processed Versus Unprocessed Foods on Glucocorticoid Secretion in Healthy Individuals","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Eleonora Seelig","has_results":false},{"nct_id":"NCT05167084","title":"Acute Consequences Of Food-induced Glucocorticoid Secretion In Healthy Individuals","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Eleonora Seelig","has_results":false},{"nct_id":"NCT04659915","title":"Counteracting Deleterious Metabolic Glucocorticoid Effects With Metformin","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Eleonora Seelig","has_results":false},{"nct_id":"NCT04941404","title":"A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT05619770","title":"Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":6,"lead_sponsor_name":"101 Therapeutics","has_results":false}],"total":39},"guidelines":[],"source":"Drug Landscape verified database"}